Cefiderocol Compared With Meropenem for Nosocomial Pneumonia Treatmenthttps://www.empr.com/home/news/cefiderocol-compared-with-meropenem-for-nosocomial-pneumonia-treatment/
FDA Approves Ceftolozane/Tazobactam for HABP/VABPhttps://www.contagionlive.com/news/fda-approves-ceftolozanetazobactam-for-nosocomial-pneumonia
Phage therapy: The antibiotics alternativehttps://www.smh.com.au/lifestyle/health-and-wellness/as-antibiotic-resistance-threatens-millions-of-lives-is-phage-therapy-the-best-alternative-20191128-p53f01.html
Stewardship / Resistance Scan for Sep 26, 2019 | CIDRAPhttp://www.cidrap.umn.edu/news-perspective/2019/09/stewardship-resistance-scan-sep-26-2019